POWSZECHNY ZAKLAD UBEZP./ PLPZU0000011 /
03.06.2024 8:08:41 | Изменение -0.3300 | Объем сделки | Бид17:27:11 | Предложение17:32:08 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
11.5650EUR | -2.77% | 0 Оборот: 0.0000 |
11.5600Величина цены спроса: 500 | 11.8700Величина цены предложения: 500 | 10.07 млрдEUR | - | - |
GlobeNewswire
17:35
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
GlobeNewswire
17:33
Natiivo Hospitality Expands with New South Florida Projects, Hires Yoav Gery as President
GlobeNewswire
17:30
Titan.ium Platform Announces Collaboration with Nokia Improving Security for Global Telecommunicatio...
GlobeNewswire
17:20
New CryptoStaking Strategies Introduced by CryptoHeap to Maximize Investor Returns
GlobeNewswire
17:15
DEADLINE ALERT for HRT and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions...
GlobeNewswire
17:13
Los Angeles Student Wins NFTE West (Southern California) Youth Entrepreneurship Challenge
GlobeNewswire
17:12
Kirby McInerney LLP Reminds Harbor Diversified, Inc. (HRBR) Investors of Class Action Filing and Enc...
GlobeNewswire
17:11
Kirby McInerney LLP Reminds Global Cord Blood Corporation (CORBF) Investors of Upcoming Deadline in ...
GlobeNewswire
17:11
Infuse Summer Fun In Your Coffee With Bones Coffee Company’s New, Limited-Edition Summer Flavors
GlobeNewswire
17:02
Cambria Investment Management and Chesapeake Capital Corporation Announces the Launch of the Cambria...
GlobeNewswire
17:00
MidWestOne Financial Group Welcomes Three Key Executive Leaders to the Organization
GlobeNewswire
17:00
Zevra Therapeutics Announces Positive Final Results from Phase 2 Clinical Trial of KP1077 for Idiopa...
GlobeNewswire
17:00
Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница